Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.43+0.01 (+0.70%)
Close on Nov 18, 2026Market cap $53.52MP/E –Yield –
Tenax Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Tenax Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $0. For fiscal 2025 it was $0. The highest annual figure on record is $1.19M in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | – |
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2015 | Apr 30, 2015 | $49.29K | -69.0% |
| FY2014 | Apr 30, 2014 | $158.93K | -86.7% |
| FY2013 | Apr 30, 2013 | $1.19M | +227.4% |
| FY2012 | Apr 30, 2012 | $363.78K | +252.6% |
| FY2011 | Apr 30, 2011 | $103.17K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $0 | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2015CQ1 2015 | Apr 30, 2015 | $49.29K | – |
| Q3 FY2015CQ4 2014 | Jan 31, 2015 | $0 | – |
See a number that looks wrong?